Dental Care Clinics in Wilmington, CA Accepting Medicare
17 Dental Care Clinics found. Showing 1 - 17
 Farwest Dental Group, Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1704 N Avalon Blvd, Wilmington, CA 90744 Phone: 310-835-5030 Fax: 310-835-6090 |
Benjamin Bao Le Dmd, Inc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1702 N Avalon Blvd, Wilmington, CA 90744 Phone: 310-835-0251 Fax: 310-835-1690 |
Wilmington Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1610 N Avalon Blvd, Wilmington, CA 90744 Phone: 310-835-3131 |
Farjam Shadaiee Yashmerani, Dds Inc. Dentist Medicare: Not Enrolled in Medicare Practice Location: 445 E Anaheim St Ste M, Wilmington, CA 90744 Phone: 310-835-3535 Fax: 310-835-3030 |
Iraj Nouri Dds Inc. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1239 N Avalon Blvd, Wilmington, CA 90744 Phone: 310-518-2697 Fax: 310-518-6864 |
Kanwal J.s. Virk Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 221 W Anaheim St, Wilmington, CA 90744 Phone: 310-233-7777 |
Caspar L. Sung Dds Inc. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 414 W Pacific Coast Hwy, Wilmington, CA 90744 Phone: 310-518-3522 |
Bright Now Dental - Wilmington Dentist Medicare: Not Enrolled in Medicare Practice Location: 1610 N Avalon Blvd, Wilmington, CA 90744 Phone: 310-835-3131 Fax: 310-835-0088 |
Newport Dental - Wilmington Dentist - Dental Public Health Medicare: Not Enrolled in Medicare Practice Location: 1610 N Avalon Blvd, Wilmington, CA 90744 Phone: 310-835-3131 |
Newport Dental Wilmington Ortho Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 1610 N Avalon Blvd, Wilmington, CA 90744 Phone: 800-816-3519 |
Dental Plus Dentist Medicare: Not Enrolled in Medicare Practice Location: 104 W Anaheim St Ste C, Wilmington, CA 90744 Phone: 310-830-3452 |
Wilmington Dental Group Dentist Medicare: Not Enrolled in Medicare Practice Location: 414 W Pacific Coast Hwy, Wilmington, CA 90744 Phone: 310-518-3522 |
Summer Smile Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1239 N Avalon Blvd Ste A, Wilmington, CA 90744 Phone: 310-518-2697 Fax: 310-518-6864 |
Farwest Dental Group Dentist Medicare: Not Enrolled in Medicare Practice Location: 1704 N Avalon Blvd, Wilmington, CA 90744 Phone: 310-835-5130 Fax: 310-835-6090 |
Vaishali Patel Dds, Inc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 207 W G St, Wilmington, CA 90744 Phone: 310-549-2400 Fax: 310-834-0634 |
Farwest Dental Group Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1704 N Avalon Blvd, Wilmington, CA 90744 Phone: 310-835-5130 Fax: 310-835-6090 |
Dental Plus Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 104 W Anaheim St, Suite C, Wilmington, CA 90744 Phone: 818-786-6000 Fax: 818-786-8820 |
News Archive
Scientists discover technique to help 'friendly bacteria'
There is currently a great deal of interest in the health-associated properties of probiotics, also known as 'beneficial' or 'friendly' bacteria, and prebiotics, the food needed for the growth of probiotic when inside our bodies.
Ceremed awarded NIH SBIR grant to develop soluble carrier for topical delivery of antibiotic Vancomycin
Ceremed, Inc. was awarded a Small Business Innovation Research (SBIR) grant, the company's third in a series of grants from the National Institutes of Health to develop a versatile soluble carrier with bone hemostatic properties for targeted delivery of therapeutic agents directly to surgical sites. The recently awarded grant will aid Ceremed in its effort to develop a soluble carrier to topically deliver the antibiotic Vancomycin.
Mediterranean diet beneficial to heart health: Study
In countries bordering the Mediterranean Sea, heart disease is less common than in the United States. Researchers believe that foods common to Greece and southern Italy are a major reason for this difference.
AACR rapid and dramatic responses in TRK fusion patients
Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced new results from its Phase 1 open-label, dose-escalation trial of LOXO-101, a selective inhibitor of tropomyosin receptor kinase (TRK) signaling molecules, and the first preclinical data for its RET and FGFR programs. The data are being presented at the 2015 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
› Verified 8 days ago